Ahmad Nadeem, Baitha Kanchan Sone Lal, Pawar Shashi S, Mohsin Farhan, Prakash Prem, Raj Rishika, Mondal Saptarshi
General Surgery, Indira Gandhi Institute of Medical Sciences (IGIMS) Patna, Patna, IND.
Surgical Oncology, Indira Gandhi Institute of Medical Sciences (IGIMS) Patna, Patna, IND.
Cureus. 2025 Jul 24;17(7):e88664. doi: 10.7759/cureus.88664. eCollection 2025 Jul.
This study aimed to evaluate the implementation of the Enhanced Recovery After Surgery (ERAS®) protocol in patients undergoing colorectal cancer resections at a tertiary care center in India, and to assess whether protocol compliance influences the length of hospital stay and postoperative complications.
We conducted a prospective observational study of 50 consecutive patients undergoing colorectal cancer resection surgery at Indira Gandhi Institute of Medical Sciences (IGIMS), Patna, between May 2024 and April 2025. A 16-item ERAS® protocol was implemented, and compliance was measured. Primary outcomes included the length of hospital stay, postoperative complications (classified according to the Clavien-Dindo classification), and 30-day readmission rates.
Overall compliance with the ERAS® protocol was 78.6% across all 50 patients. Mean length of stay was 6.3 ± 2.7 days, with significantly shorter stays in patients who achieved >80% compliance (24/50 patients, 5.2 ± 1.8 days) compared with those below this threshold (26/50, 7.6 ± 3.0 days; p=0.003). The overall complication rate was 24% (12/50), while major complications (Clavien-Dindo grade ≥ III) occurred in 8% (4/50). The 30-day readmission rate was 4% (2/50). Greater compliance was associated with fewer overall complications (4/24 (16.7%) vs. 11/26 (42.3%); p=0.038), although it did not significantly influence major complications or readmissions.
The implementation of the ERAS® protocol in colorectal cancer surgery is feasible in a resource-constrained setting, with acceptable compliance rates. Higher compliance was associated with shorter hospital stay and reduced overall complication rates. The protocol can be safely applied to patients undergoing colorectal cancer surgeries, potentially improving outcomes and resource utilization.
本研究旨在评估印度一家三级医疗中心对接受结直肠癌切除术患者实施加速康复外科(ERAS®)方案的情况,并评估方案依从性是否会影响住院时间和术后并发症。
我们对2024年5月至2025年4月期间在巴特那英迪拉·甘地医学科学研究所(IGIMS)连续接受50例结直肠癌切除手术的患者进行了前瞻性观察研究。实施了一项包含16项内容的ERAS®方案,并对依从性进行了测量。主要结局包括住院时间、术后并发症(根据Clavien-Dindo分类法分类)和30天再入院率。
50例患者中,ERAS®方案的总体依从率为78.6%。平均住院时间为6.3±2.7天,依从率>80%的患者(24/50例患者,5.2±1.8天)的住院时间明显短于低于该阈值的患者(26/50例,7.6±3.0天;p=0.003)。总体并发症发生率为24%(12/50),而严重并发症(Clavien-Dindo分级≥III级)发生率为8%(4/50)。30天再入院率为4%(2/50)。更高的依从性与总体并发症较少相关(4/24(16.7%)对11/26(42.3%);p=0.038),尽管它对严重并发症或再入院没有显著影响。
在资源有限的环境中,在结直肠癌手术中实施ERAS®方案是可行的,依从率可以接受。更高的依从性与更短的住院时间和更低的总体并发症发生率相关。该方案可安全应用于接受结直肠癌手术的患者,可能改善治疗效果和资源利用。